Vanda Pharmaceuticals Inc. (VNDA)

18.70
NASDAQ : Health Technology
Prev Close 17.65
Day Low/High 17.60 / 18.95
52 Wk Low/High 11.90 / 18.99
Avg Volume 492.30K
Exchange NASDAQ
Shares Outstanding 45.44M
Market Cap 790.62M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

VNDA Makes Notable Cross Below Critical Moving Average

In trading on Friday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $15.29, changing hands as low as $15.15 per share. Vanda Pharmaceuticals Inc shares are currently trading down about 1.9% on the day.

First Week of February 2018 Options Trading For Vanda Pharmaceuticals (VNDA)

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Interesting VNDA Put And Call Options For January 2018

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Relative Strength Alert For Vanda Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals Enters Oversold Territory (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals (VNDA) Shares Cross Below 200 DMA

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $15.26, changing hands as low as $14.65 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 5.5% on the day.

Vanda Pharmaceuticals To Announce Third Quarter 2017 Financial Results On November 7, 2017

Vanda Pharmaceuticals To Announce Third Quarter 2017 Financial Results On November 7, 2017

Conference Call and Webcast to Follow

Interesting VNDA Put And Call Options For November 17th

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new November 17th contracts and identified one put and one call contract of particular interest.

Summit Therapeutics Stock Gets Smoked After IPO Pricing

Summit Therapeutics Stock Gets Smoked After IPO Pricing

Summit Therapeutics and Epizyme are raising cash to fund new drug development.

Vanda Pharmaceuticals To Announce Second Quarter 2017 Financial Results On August 2, 2017

Vanda Pharmaceuticals To Announce Second Quarter 2017 Financial Results On August 2, 2017

Conference Call and Webcast to Follow

Vanda Pharmaceuticals (VNDA) Shares Cross Above 200 DMA

In trading on Tuesday, shares of Vanda Pharmaceuticals Inc crossed above their 200 day moving average of $15.01, changing hands as high as $15.30 per share. Vanda Pharmaceuticals Inc shares are currently trading up about 8.2% on the day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADGE, ANTX, HY, RTRX, VNDA Downgrades: CELP, FORD, GRC, HMSY, LNCE, MET, NCI, OUT, PLPC, UBA Initiations: ADAP, DGLT Read on to get TheStreet Quant Ratings' detailed report:

First Week of May 19th Options Trading For Vanda Pharmaceuticals (VNDA)

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

VNDA Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $14.20, changing hands as low as $14.10 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.4% on the day.

VNDA Crosses Below Key Moving Average Level

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $13.75, changing hands as low as $13.55 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.1% on the day.

First Week of April 21st Options Trading For Vanda Pharmaceuticals

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

VNDA Crosses Below Key Moving Average Level

VNDA Crosses Below Key Moving Average Level

In trading on Monday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $13.24, changing hands as low as $13.00 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.5% on the day.

Vanda Pharmaceuticals is Now Oversold (VNDA)

Vanda Pharmaceuticals is Now Oversold (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting VNDA Put And Call Options For February 17th

Interesting VNDA Put And Call Options For February 17th

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the February 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new February 17th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: C (Hold)